Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
acknowledged, Africa, alert, Alzheimer, AMCo, answer, Apriso, arbitration, Arformoterol, atrophy, Augu, Aurobindo, Australian, background, bifurcated, Black, Brovana, Bulgarian, capsule, carbon, catalog, certainty, Certiorari, characterization, Clara, Closeout, colchicine, compliant, compound, confident, conservation, contractor, correctedamended, cyclical, Cytomel, Dedicated, deemedforum, Delhi, Delta, diet, disallowance, disinfectant, domicile, DSS, eager, EasternDistrict, EBSI, eighteen, energy, enrichment, entail, Eq, ergonomic, Ethinyl, Etonogestrel, extreme, fairvalue, Famotidine, fluid, foren, fueled, gas, GDP, gender, GHG, Gilead, GmbH, great, Green, greenhouse, Heritage, HIV, home, horizontal, Humana, Ibuprofen, ID, immunology, implausible, indirectly, indolent, inequality, interchangeable, interlocutory, Irvine, ITC, Lanham, Latinx, lethal, lev, LGBTQ, libel, lifesaving, Liothyronine, Malate, male, MDD, MDR, meantime, MedinCell, milar, mindset, Minnesota, misappropriating, modag, module, monopolization, MSA, multigenerational, NaN, Narcan, Nassau, neurodegeneration, neuroscience, nuevo, nutrition, NuvaRing, Omicron, OMQ, onset, onsite, outlined, output, pace, Parkinson, paused, Peruvian, Pharmascience, pivotal, plausibly, preliminarily, Programme, Prolia, promulgated, psychological, Racketeer, ranibizumab, reassert, recommence, reconsideration, refractory, refreshed, relaxation, reopening, resilience, Ring, rulemaking, Sandoz, Santa, satisfactorily, scarcity, setup, shortage, si, sleep, societal, soft, sol, sponsorship, spray, Suffolk, Sunitinib, surveillance, Sutent, Tartrate, Thiola, Tiopronin, Tribunal, unconditional, unintended, unjust, Urban, victory, Viread, visitor, Washington, Waymade, weather, whilst, Writ, wrongdoing
Removed:
Aetna, afforded, analyzed, anti, anticipation, barring, blend, bortezomib, Bulgaria, capitalizing, closest, Cloud, comparability, converted, counterclaim, Croatia, CVS, Czech, de, disclosing, dissolution, DPA, draft, educational, Endo, ester, eventually, Gamble, goal, headache, Herceptin, hosting, Hungary, improperly, IMS, includingpre, inequitable, inform, infrequent, initiative, interaction, invalidity, Janssen, label, mannitol, Master, memantine, Millennium, Namenda, nonrecurring, opening, overturn, overturning, pantoprazole, PGT, plc, prejudgment, presenting, Procter, Protonix, recurring, redeem, retroactively, ruled, separation, shortened, slowdown, stoppage, succeeded, unaudited, unconstitutional, unify, unscheduled, Velcade, yield
Filing tables
Filing exhibits
Related press release
Associated TEVA transcripts
TEVA similar filings
Filing view
External links
Exhibit 10.25
Private and Confidential
July 27, 2021
To: Mark Sabag
Teva Global ID: 31507
Dear Mark,
Congratulations on your appointment as Executive Vice President, International Markets Commercial.
Effective Date: August 15, 2021
Your compensation will remain the same as prior to your appointment and the terms shall be as determined in your current employment agreement.
We strongly believe in the company and in your contribution to its success. We look forward to your continued commitment towards Teva’s short and long-term strategic goals.
Sincerely,
Kåre Schultz
President and Chief Executive Officer
Teva Pharmaceutical Industries Ltd.
124 Dvora HaNevi’a St., Tel Aviv 6944020 Israel | www.tevapharm.com